Area of research
Molecular Biology · Oncology
Research interest
Research focused on Cancer research and Breast cancer, with related work in Autophagy, Sphingosine kinase 1, Carcinogenesis. Notable publications include 'Targeting glucose‐6‐phosphate dehydrogenase by 6‐AN induces ROS ‐mediated autophagic cell death in breast cancer', 'G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression', and 'Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer'.
<scp>MCL</scp> restrained <scp>ROS/AKT/ASAH1</scp> pathway to therapy tamoxifen resistance breast cancer by stabilizing <scp>NRF2</scp>
Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer
G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma
Targeting glucose‐6‐phosphate dehydrogenase by <scp>6‐AN</scp> induces <scp>ROS</scp> ‐mediated autophagic cell death in breast cancer
Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery
Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)
Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC
Targeting estrogen-mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer